The dorsal striatum is a key region in motor behavior and motor disorders such as Parkinson’s and Huntington's diseases. We expressed designer receptors exclusively activated by designer drugs (DREADD) in D1 dopamine receptor-expressing neurons in the dorsal striatum in mice and investigated the behavioral and BOLD signal changes during the neuronal activation by clozapine-N-oxide (CNO) treatment. The increased BOLD signals with no susceptibility artifact in the dorsal striatum and the correlated BOLD signal changes in several regions including the substantia nigra and the globus pallidus were observed after CNO injection.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords